SUKHCHAIN SAMRA: Open Payments
NPI 1073032447 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,394 in 138 payments from 24 companies in 2025. Trend: 2023 $2,406 · 2024 $2,907 · 2025 $2,394
Food & beverage: $2,286Education: $108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $613 |
| Janssen Biotech, Inc. | 19 | $248 |
| Incyte Corporation | 19 | $218 |
| E.R. Squibb & Sons, L.L.C. | 9 | $213 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $207 |
| GENZYME CORPORATION | 6 | $168 |
| LEO Pharma Inc. | 5 | $100 |
| Amgen Inc. | 5 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| UCB, Inc. | 3 | $76 |
Products named: RINVOQ, SKYRIZI, TREMFYA, DUPIXENT, Sotyktu, OPZELURA, Otezla, Bimzelx.
Industry payments across CA — which companies pay providers there.
